ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2021.0.152 2021.0.152 2021-12-312021-12-31false2021-01-0111falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12871142 2021-01-01 2021-12-31 12871142 2020-09-10 2020-12-31 12871142 2021-12-31 12871142 2020-12-31 12871142 1 2021-01-01 2021-12-31 12871142 2 2021-01-01 2021-12-31 12871142 d:Director2 2021-01-01 2021-12-31 12871142 e:Goodwill 2021-01-01 2021-12-31 12871142 e:Goodwill 2021-12-31 12871142 e:Goodwill 2020-12-31 12871142 e:CurrentFinancialInstruments 2021-12-31 12871142 e:CurrentFinancialInstruments 2020-12-31 12871142 e:CurrentFinancialInstruments e:WithinOneYear 2021-12-31 12871142 e:CurrentFinancialInstruments e:WithinOneYear 2020-12-31 12871142 e:ShareCapital 2021-01-01 2021-12-31 12871142 e:ShareCapital 2021-12-31 12871142 e:ShareCapital 2020-09-10 2020-12-31 12871142 e:ShareCapital 2020-12-31 12871142 e:OtherMiscellaneousReserve 2021-01-01 2021-12-31 12871142 e:OtherMiscellaneousReserve 2021-12-31 12871142 e:OtherMiscellaneousReserve 1 2021-01-01 2021-12-31 12871142 e:OtherMiscellaneousReserve 2 2021-01-01 2021-12-31 12871142 e:OtherMiscellaneousReserve 2020-12-31 12871142 e:RetainedEarningsAccumulatedLosses 2021-01-01 2021-12-31 12871142 e:RetainedEarningsAccumulatedLosses 2021-12-31 12871142 e:RetainedEarningsAccumulatedLosses 1 2021-01-01 2021-12-31 12871142 e:RetainedEarningsAccumulatedLosses 2 2021-01-01 2021-12-31 12871142 e:RetainedEarningsAccumulatedLosses 2020-09-10 2020-12-31 12871142 e:RetainedEarningsAccumulatedLosses 2020-12-31 12871142 d:OrdinaryShareClass1 2021-01-01 2021-12-31 12871142 d:OrdinaryShareClass1 2021-12-31 12871142 d:OrdinaryShareClass1 2020-12-31 12871142 d:FRS102 2021-01-01 2021-12-31 12871142 d:AuditExempt-NoAccountantsReport 2021-01-01 2021-12-31 12871142 d:FullAccounts 2021-01-01 2021-12-31 12871142 d:PrivateLimitedCompanyLtd 2021-01-01 2021-12-31 12871142 e:Goodwill e:ExternallyAcquiredIntangibleAssets 2021-01-01 2021-12-31 12871142 6 2021-01-01 2021-12-31 12871142 e:Goodwill e:OwnedIntangibleAssets 2021-01-01 2021-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12871142









BAYES ALPHA LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2021

 
BAYES ALPHA LIMITED
REGISTERED NUMBER: 12871142

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2021

2021
2020
Note
£
£

Fixed assets
  

Intangible assets
 4 
3,909,251
-

Investments
 5 
149,393
880

  
4,058,644
880

Current assets
  

Debtors: amounts falling due within one year
 6 
20,165,067
30

Cash at bank and in hand
 7 
895
-

  
20,165,962
30

Creditors: amounts falling due within one year
 8 
(705,045)
(26,020)

Net current assets/(liabilities)
  
 
 
19,460,917
 
 
(25,990)

Total assets less current liabilities
  
23,519,561
(25,110)

  

Net assets/(liabilities)
  
23,519,561
(25,110)


Capital and reserves
  

Called up share capital 
 9 
30
30

Warrants classified as equity
 10 
24,379,737
-

Profit and loss account
 10 
(860,206)
(25,140)

  
23,519,561
(25,110)


Page 1

 
BAYES ALPHA LIMITED
REGISTERED NUMBER: 12871142
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2021

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 5 April 2023.




Stephen Gerry
Director

The notes on pages 5 to 10 form part of these financial statements.

Page 2

 
BAYES ALPHA LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2021


Called up share capital
Warrants classified as equity
Profit and loss account
Total equity

£
£
£
£

At 1 January 2021
30
-
(25,140)
(25,110)


Comprehensive income for the year

Loss for the year

-
-
(779,807)
(779,807)

Other movement type 1
-
-
(55,259)
(55,259)


Other comprehensive income for the year
-
-
(55,259)
(55,259)


Total comprehensive income for the year
-
-
(835,066)
(835,066)


Contributions by and distributions to owners

Warrants issued in the year
-
24,379,737
-
24,379,737


Total transactions with owners
-
24,379,737
-
24,379,737


At 31 December 2021
30
24,379,737
(860,206)
23,519,561


The notes on pages 5 to 10 form part of these financial statements.

Page 3

 
BAYES ALPHA LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2020


Called up share capital
Profit and loss account
Total equity

£
£
£


Comprehensive income for the period

Loss for the period

-
(25,140)
(25,140)


Other comprehensive income for the period
-
-
-


Total comprehensive income for the period
-
(25,140)
(25,140)


Contributions by and distributions to owners

Shares issued during the period
30
-
30


Total transactions with owners
30
-
30


At 31 December 2020
30
(25,140)
(25,110)


The notes on pages 5 to 10 form part of these financial statements.

Page 4

 
BAYES ALPHA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

1.


General information

Bayes Alpha Limited (the 'Company') is a private company, limited by shares and incorporated in England and Wales. The address of the registered office is Mazars, 30 Old Bailey, London, EC4M 7AU. 
The Company's registered number is 13028897.
The Company's principal activity is that of a holding company.
The functional currency of the Company is USD and the presentational currency is GBP. Monetary amounts in these financial statements are rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The Director's have considered the budgets and cashflow forecasts for the Company and confirmed that the Company will be able to meet its liabilities as they fall due and so the financial statements have been prepared on a going concern basis. 
At the date of signing the financial statements, the Directors conclude that the Company can continue to adopt the going concern basis of preparation for the financial statements due to full financial support available from the other group companies.

Page 5

 
BAYES ALPHA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

2.Accounting policies (continued)

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional currency is USD. This differs from the presentational currency which is GBP. The reason for the difference is that GBP is the currency of the primary economic environment in which the Company operates.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.4

Intangible assets

Goodwill
Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of Comprehensive Income over its useful economic life.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
2.5

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 6

 
BAYES ALPHA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

2.Accounting policies (continued)

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.

Financial assets and liabilities are offset and the net amount reported in the Statement of Financial Position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 7

 
BAYES ALPHA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2020 - 1).


4.


Intangible assets




Goodwill

£



Cost


Additions
4,170,595


Foreign exchange gain
103,583



At 31 December 2021

4,274,178



Amortisation


Charge for the year on owned assets
364,927



At 31 December 2021

364,927



Net book value



At 31 December 2021
3,909,251



At 31 December 2020
-




5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2021
880


Additions
144,632


Foreign exchange gain
3,881



At 31 December 2021
149,393




Page 8

 
BAYES ALPHA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

6.


Debtors

2021
2020
£
£


Trade debtors
32,252
-

Amounts owed by group undertakings
168,095
-

Amounts owed by associated undertakings
9,526,199
-

Other debtors
10,438,491
-

Called up share capital not paid
30
30

20,165,067
30



7.


Cash and cash equivalents

2021
2020
£
£

Cash at bank and in hand
895
-

895
-



8.


Creditors: Amounts falling due within one year

2021
2020
£
£

Trade creditors
11,662
-

Amounts owed to group undertakings
685,073
26,020

Accruals and deferred income
8,310
-

705,045
26,020



9.


Share capital

2021
2020
£
£
Allotted, called up and partly paid



60,000 (2020 - 60,000) Ordinary shares of £0.0005 each
30
30


Page 9

 
BAYES ALPHA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

10.


Reserves

Warrants classified as equity

Warrants provide the purchaser the right to purchase a fixed number of shares for a fixed exercise price.

Profit and loss account

This reserve represents the cumulative profits and losses, after payment of dividends.


11.


Related party transactions

The Company has taken advantage of the exemption available in accordance with FRS 102 Section 1 A Appendix C.34-36 'Related party disclosure' of FRS 102 not to disclose transactions entered into between two or more members of a group that are wholly owned.


12.


First time adoption of FRS 102

The policies applied under the entity's previous accounting framework are not materially different to FRS 102 and have not impacted on equity or profit or loss.

 
Page 10